We Can Medicines Balance Sheet Health
Financial Health criteria checks 4/6
We Can Medicines has a total shareholder equity of NT$816.3M and total debt of NT$279.8M, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are NT$2.9B and NT$2.0B respectively. We Can Medicines's EBIT is NT$23.9M making its interest coverage ratio 1. It has cash and short-term investments of NT$160.5M.
Key information
34.3%
Debt to equity ratio
NT$279.79m
Debt
Interest coverage ratio | 1x |
Cash | NT$160.53m |
Equity | NT$816.35m |
Total liabilities | NT$2.04b |
Total assets | NT$2.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6929's short term assets (NT$1.3B) exceed its short term liabilities (NT$1.0B).
Long Term Liabilities: 6929's short term assets (NT$1.3B) exceed its long term liabilities (NT$999.4M).
Debt to Equity History and Analysis
Debt Level: 6929's net debt to equity ratio (14.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6929's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6929's debt is well covered by operating cash flow (50%).
Interest Coverage: 6929's interest payments on its debt are not well covered by EBIT (1x coverage).